Warning that thousands in UK may die early from bowel cancer

Organisation: Position: Deadline Date: Location:

A dramatic rise in bowel cancer cases is set to sweep in the UK in the wake of the COVID-19 outbreak, The Guardian report that the doctors and scientists have warned. They said they feared that the halting of screening for the condition will lead to thousands of people dying early from the disease.

Bowel cancer is the UK’s second biggest cancer killer after lung cancer. Last year it caused the deaths of more than 16,000 people, a rate of more than 45 individuals a day. Tumours spread aggressively if left untreated but can be pinpointed – using special screening techniques – in their early stages. As a result, doctors can cut out tumours before they spread and patients often make complete recoveries.

However, since March, bowel cancer screening has been effectively halted because of the COVID-19 pandemic.

The report says the early detection of bowel cancer is carried by spotting blood in stool samples. Test kits are posted to men and women over the age of 60 – individuals who have the highest risk of getting bowel cancer, along with those who are obese or have family histories of the disease. Stool samples are then sent to test centres.

However, test kits for identifying individuals who have blood in their stools are no longer being sent out while endoscopy examinations have been stopped except for a handful of emergency cases, effectively halting all UK bowel cancer screening.

And that cessation of a life-saving service is now a major concern, said Professor Mark Lawler, of Queens University, Belfast. “If a person with bowel cancer is not identified early on, their tumour will continue to grow. It will develop until it reaches an advanced stage when it will be much, much more difficult to tackle.

 

Full report in The Guardian

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.